📇 Rhumatologue · NANCY · (54) · Libéral
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Praticien-chercheur
14 articles scientifiques publiés — formation continue solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
146.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
PREFECTURE DE MEURTHE ET MOSELLE
PREFECTURE 1 RUE PREFET CLAUDE ERIGNAC, 54000 NANCY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Orthopedics · 2013
Intra-articular injections of platelet-rich plasma (PRP) and hyaluronic acid (HA) represent efficacious medical treatments for osteoarthritis (OA), although no comparative study on long-term efficacy in hip OA exists. The goals of the current study were to compare the clinical efficacy of PRP vs HA at 12 months of follow-up in patients with hip OA and evaluate the influence of the type of infiltration and patient age, sex, body mass index, and degree of OA on temporal clinical evolution. One hundred patients with chronic unilateral symptomatic hip OA were consecutively enrolled and randomly assigned to 1 of 2 groups: group A received PRP and group B received HA administered via intra-articular ultrasound-guided injections. Patients were evaluated at baseline and after 1, 3, 6, and 12 months using the Harris Hip Score (HHS) and visual analog scale (VAS). An overall improvement was detected in both groups between 1- and 3-month follow-up. Despite a slightly progressive worsening between 6- and 12-month follow-up, the final clinical scores remained higher compared with baseline ( P <.0005), with no significant differences between PRP and HA. Regarding clinical temporal evolution, multivariate analysis showed that HHS was not influenced by the type of infiltration, patient age, sex, body mass index, or degree of OA, whereas a significant association was detected between OA grade IV and VAS evolution ( P <.0005). Intra-articular injections of PRP are efficacious in terms of functional improvement and pain reduction but are not superior to HA in patients with symptomatic hip OA at 12-month follow-up.
The American journal of sports medicine · 2007
Background Revision anterior cruciate ligament surgery remains challenging. Purpose To analyze the authors’ experience with revision anterior cruciate ligament surgery and determine the association between stability and functional results. Study Design Case series; Level of evidence, 4. Methods Between 1991 and 2002, 95 of 102 patients who underwent revision anterior cruciate ligament reconstruction at the authors’ institution met the criteria for inclusion in the study. Of those, the 63 (66%) who returned for complete clinical and radiologic evaluation (mean follow-up, 72.7 months) formed the study group. Subjective evaluation focused on return to sports, arthritic symptoms, and subjective International Knee Documentation Committee criteria. Clinical evaluation included examination, KT-1000 arthrometer and functional testing, and radiographic analysis of alignment and arthritis. Results Based on International Knee Documentation Committee subjective scores and return to sports, results were rated as excellent/good in 45 patients (71%), fair in 6 (10%), and poor in 12 (19%). A grade IA or IIA Lachman and a KT-1000 arthrometer side-to-side difference of <3 mm (32/63 patients) was associated with a good/excellent result (P < .05). The mechanical axis was midline in 78% (49/63 patients). Radiographic arthritis (16 patients, 25%) was associated with duration of instability after primary failure (P < .03). Return to sports occurred in 59% (37/63 patients). Sixteen patients (25%) required a second revision surgery. Conclusion Revision anterior cruciate ligament surgery allowed approximately 60% of patients to go back to sports, most of them at lower levels than their prerevision function. Instrumented laxity of <3 mm was associated with a better result. Radiographic arthritis was associated with duration of instability symptoms after primary failure. Patients who undergo revision anterior cruciate ligament surgery should be counseled as to the expected outcome and cautioned that this procedure probably represents a salvage situation and may not allow them to return to their desired levels of function.
The American journal of sports medicine · 2019
Background: Labral reconstruction has demonstrated short-term benefit for the treatment of irreparable labral tears. Nonetheless, there is a scarcity of evidence for midterm outcomes of this treatment. Hypotheses: Arthroscopic segmental reconstruction in the setting of irreparable labral tears would show improvement in patient-reported outcomes (PROs) and high patient satisfaction at minimum 5-year follow-up. Second, primary labral reconstruction (PLRECON) would result in similar improvement in PROs at minimum 5-year follow-up when compared with a matched-pair primary labral repair (PLREPAIR) control group. Study Design: Cohort study; Level of evidence, 3. Methods: Data from February 2008 to April 2013 were retrospectively reviewed. Patients were included if they underwent hip arthroscopy for segmental labral reconstruction in the setting of irreparable labral tear and femoroacetabular impingement, with minimum 5-year follow-up for modified Harris Hip Score, Nonarthritic Hip Score, Hip Outcome Score–Sports Specific Subscale, patient satisfaction, and visual analog scale for pain. Exclusion criteria were Tönnis osteoarthritis grade >1, prior hip conditions, or workers’ compensation claims. PLRECON cases were matched in a 1:3 ratio to a PLREPAIR control group based on age ±5 years, sex, and body mass index ±5 kg/m 2 . Results: Twenty-eight patients were eligible for the study, of which 23 (82.14%) had minimum 5-year follow-up. The authors found significant improvement from preoperative to latest follow-up in all outcome measures recorded: 17.8-point increase in modified Harris Hip Score ( P = .002), 22-point increase in Nonarthritic Hip Score ( P < .001), 25.4-point increase in Hip Outcome Score–Sports Specific Subscale ( P = .003), and a 2.9-point decrease in visual analog scale pain ratings ( P < .001). Mean patient satisfaction was 7.1 out of 10. In the nested matched-pair analysis, 17 patients who underwent PLRECON were matched to a control group of 51 patients who underwent PLREPAIR. PLRECON demonstrated comparable survivorship and comparable improvements in all PROs with the exception of patient satisfaction (6.7 vs 8.5, P = .04). Conclusion: Hip arthroscopy with segmental labral reconstruction resulted in significant improvement in PROs at minimum 5-year follow-up. PLRECON reached comparable functional outcomes when compared with a benchmark PLREPAIR control group but demonstrated lower patient satisfaction at latest follow-up.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
La Radiologia medica · 2023 · Journal Article
Levi R, Garoli F, Battaglia M, Rizzo DAA, et al.
Arthroscopy, sports medicine, and rehabilitation · 2022 · Journal Article
Lall AC, Secretov E, Battaglia MR, Chen SL, et al.
Current medical imaging · 2022 · Journal Article
Papalexis N, Ponti F, Rinaldi R, Peta G, et al.
Journal of translational autoimmunity · 2021 · Journal Article
Battaglia M, Garrett-Sinha LA
The American journal of sports medicine · 2019 · Journal Article
Domb BG, Battaglia MR, Perets I, Lall AC, et al.
The American journal of sports medicine · 2018 · Journal Article
Perets I, Rybalko D, Mu BH, Maldonado DR, et al.
Orthopedics · 2013 · Comparative Study
Battaglia M, Guaraldi F, Vannini F, Rossi G, et al.
Clinical and experimental rheumatology · 2011 · Clinical Trial
Battaglia M, Guaraldi F, Vannini F, Buscio T, et al.
The American journal of sports medicine · 2007 · Journal Article
Battaglia MJ 2nd, Cordasco FA, Hannafin JA, Rodeo SA, et al.
American journal of physical medicine · 1979 · Clinical Trial
Culic DD, Battaglia MC, Wichman C, Schmid FR
Clinical and experimental rheumatology · 2010 · Case Reports
Mancarella L, Battaglia M, Addimanda O, Pelotti P, et al.
TheScientificWorldJournal · 2012 · Journal Article
Russo E, Trevisi E, Zulian F, Battaglia MA, et al.
Journal of endocrinological investigation · 2022 · Journal Article
Biamonte E, Levi R, Carrone F, Vena W, et al.
Reumatologia clinica · 2021 · Journal Article
Bande JM, Papasidero SB, Medina MA, Santa Cruz MJ, et al.
Clinical and experimental rheumatology · 2010 · Case Reports
Mancarella L, Battaglia M, Addimanda O, Pelotti P, et al.
✨ Profil synthétique
IA · 26/05/2026Le Dr Maxime BATTAGLIA est un rhumatologue exerçant à Nancy. Ses publications sur PubMed révèlent une implication dans la recherche sur les pathologies rhumatismales, notamment l'arthrite juvénile et la spondyloarthrite. Il s'intéresse également à l'utilisation des anti-TNF et à l'impact de la qualité de vie sur les patients, ainsi qu'à l'intelligence artificielle en rhumatologie.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.